ORIC Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-5.36 | 33.49 | -116.01% | -6.25 | -14.26% |
| P/S |
|
0 | 129.83 | -100% |
|
|
| P/BV |
|
2.31 | 260.15 | -99.11% |
|
|
| P/FCF |
|
-6.02 | -180.12 | -96.66% |
|
|
| Ev/Ebitda |
|
-4 | -28.84 | -86.14% |
|
|
| Ev/S |
|
0 | 548.04 | -100% |
|
|
| Ev/FCF |
|
-4.45 | -289.87 | -98.47% |
|
|
| E/P |
|
-0.1865 | 0.0228 | -918.96% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -375.54 | -100% | 0 | 0% |
| ROE |
|
-54.73 | 106.63 | -151.33% |
|
|
| ROA |
|
-48.6 | -2.32 | 1999.07% |
|
|
| ROIC |
|
-32.1 | 0.8343 | -3947.66% |
|
|
| ROS |
|
0 | -298.59 | -100% |
|
|
| ROCE |
|
-45.57 | 3.17 | -1536.42% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0251 | 0.9426 | -102.66% | -0.0492 | -48.97% |
| Nеt Debt/Ebitda |
|
0.4436 | 1.04 | -57.53% |
|
|
| Debt/Ratio |
|
0.0116 | 0.1798 | -93.54% |
|
|
| Debt/Equity |
|
0.1276 | 1.62 | -92.12% |
|
|
| Debt/Net Income |
|
-0.0249 | -1.65 | -98.49% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5317 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8182 | -100% | ||
| DSI |
|
0 | 0.2062 | -100% |
|
|
| Average dividend growth |
|
0 | 2.29 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5169 | -100% |
|
|
| Average percentage for payments |
|
0 | 58.77 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5317 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -99.58 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
73.1 | -152.61 | -147.9% | ||
| Growth impulse Net Income in 5 years |
|
72.77 | -115.25 | -163.14% | ||
| Growth impulse FCF in 5 years |
|
147.5 | -161.2 | -191.5% | ||
| Growth impulse EPS in 5 years |
|
-45.43 | -106.31 | -57.27% |
IP Score
3.67/10
